Purchase Order VA26216P0822
Award Date 11/6/15
Potential Completion Date 9/30/16
Potential Value $91K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Cary, NC 27513, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 21 (VISN 21), a civilian agency, to Biologics, Inc., a for-profit pharmaceutical company and subsidiary of McKesson Corporation. The contract is for the supply of the pharmaceutical drug LENALIDOMIDE, a medication used for the treatment of various types of cancer. The contract has a ceiling value of $29,628.21 and an ultimate completion date of December 14, 2025. The contract was competitively...
- This federal contract award was issued by the Veterans Integrated Service Network 21 to Biologics, Inc., a for-profit pharmaceutical company and subsidiary of McKesson Corporation. The $77,455.83 firm fixed-price purchase order is for the supply of LENALIDOMIDE, a cancer medication, to federal healthcare and correctional facilities. The contract has an ultimate completion date of November 9, 2025 and was awarded on September 9, 2025. This award is part of Biologics, Inc.'s ongoing role in...
- This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 21 (VISN 21), a civilian agency within the Department of Veterans Affairs, to Biologics, Inc., a for-profit pharmaceutical company and subsidiary of McKesson Corporation. The contract is for the supply of LENALIDOMIDE 5MG NDC: 76282-0697-48, a cancer medication, with a ceiling value of $18,697.14 and a completion date of November 23, 2025. The contract was competitively awarded and does not have...
- This is a federal contract award for the provision of cancer drugs and biologics to the Federal Medical Center Carswell, a civilian agency under the Department of Justice. The prime contractor is Biologics, Inc., a for-profit pharmaceutical company that has previously provided specialty medications to government agencies like the Department of Veterans Affairs and the Bureau of Prisons. The award, valued at $21,535.58, is a firm fixed price purchase order with an ultimate completion date of...
- This is a $382,300.88 firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA) to Biocryst Pharmaceuticals Inc., a biotechnology company that specializes in developing drugs for rare diseases. The contract is for the bulk order of ORLADEYO, a drug used to treat hereditary angioedema, to support veteran healthcare. The contract is not set aside and is part of Biocryst's Federal Supply Schedule (FSS)...
- This is a $42,078.48 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of LYNPARZA 100 MG TABLET UU 120S, a prescription medication, to support federal healthcare programs. The contract has an ultimate completion date of April 24, 2025 and is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,511.33 Firm Fixed Price Delivery Order is for the supply of LYNPARZA 150 MG TABLET UU 60S, a prescription pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award, valued at $4,887.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LYNPARZA 150 MG TABLET (National Stock Number 4564545251) and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This delivery order contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Ariad Pharmaceuticals, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of prescription medications, specifically the cancer drugs Iclusig (ponatinib) and Lenvima (lenvatinib), to VA hospitals and medical centers. The contract has a firm fixed price with a potential value of $138,026.40 and was placed under the General Services...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LYNPARZA 100 MG TABLET in a quantity of 60 tablets. The order has a firm fixed price of $5,271.84 and a completion date of May 2, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...